{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:03:44Z","timestamp":1779753824349,"version":"3.53.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GERCOR and RSFN association"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46997-7","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T08:25:46Z","timestamp":1775291146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Colorectal cancer cells respond differentially to autophagy induced by tyrosine kinase inhibitors"],"prefix":"10.1038","volume":"16","author":[{"given":"Lila","family":"Louadj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorios","family":"Gerotziafas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Sabbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette K.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"46997_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"46997_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan, E. et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 72, 338\u2013344. https:\/\/doi.org\/10.1136\/gutjnl-2022-327736 (2023).","journal-title":"Gut"},{"key":"46997_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4251\/wjgo.v7.i11.271","volume":"7","author":"F Burada","year":"2015","unstructured":"Burada, F. Autophagy in colorectal cancer: An important switch from physiology to pathology. WJGO 7, 271. https:\/\/doi.org\/10.4251\/wjgo.v7.i11.271 (2015).","journal-title":"WJGO"},{"key":"46997_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/path.2697","volume":"221","author":"D Glick","year":"2010","unstructured":"Glick, D., Barth, S. & Macleod, K. F. Autophagy: cellular and molecular mechanisms. J. Pathol. 221, 3\u201312. https:\/\/doi.org\/10.1002\/path.2697 (2010).","journal-title":"J. Pathol."},{"key":"46997_CR5","doi-asserted-by":"publisher","first-page":"4701275","DOI":"10.1155\/2018\/4701275","volume":"2018","author":"KF Cooper","year":"2018","unstructured":"Cooper, K. F. Till Death Do Us Part: The Marriage of Autophagy and Apoptosis. Oxidative Med. Cell. Longev. 2018, 4701275. https:\/\/doi.org\/10.1155\/2018\/4701275 (2018).","journal-title":"Oxidative Med. Cell. Longev."},{"key":"46997_CR6","unstructured":"Vargas_The mechanisms. and roles of selective autophagy in mammals_combined.pdf n.d."},{"key":"46997_CR7","doi-asserted-by":"publisher","first-page":"100152","DOI":"10.1016\/j.cellin.2024.100152","volume":"3","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y., Liu, F., Jian, F. & Rong, Y. Recent progresses in the late stages of autophagy. Cell. Insight. 3, 100152. https:\/\/doi.org\/10.1016\/j.cellin.2024.100152 (2024).","journal-title":"Cell. Insight"},{"key":"46997_CR8","doi-asserted-by":"publisher","first-page":"104224","DOI":"10.1016\/j.drudis.2024.104224","volume":"29","author":"A Khalafiyan","year":"2024","unstructured":"Khalafiyan, A. et al. Highlighting roles of autophagy in human diseases: a perspective from single-cell RNA sequencing analyses. Drug Discovery Today. 29, 104224. https:\/\/doi.org\/10.1016\/j.drudis.2024.104224 (2024).","journal-title":"Drug Discovery Today"},{"key":"46997_CR9","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3390\/cancers14071637","volume":"14","author":"E Taucher","year":"2022","unstructured":"Taucher, E., Mykoliuk, I., Fediuk, M., Smolle-Juettner, F-M. & Autophagy Oxidative Stress and Cancer Development. Cancers 14, 1637. https:\/\/doi.org\/10.3390\/cancers14071637 (2022).","journal-title":"Cancers"},{"key":"46997_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.biopha.2018.05.007","volume":"104","author":"S Saha","year":"2018","unstructured":"Saha, S., Panigrahi, D. P., Patil, S. & Bhutia, S. K. Autophagy in health and disease: A comprehensive review. Biomed. Pharmacother. 104, 485\u2013495. https:\/\/doi.org\/10.1016\/j.biopha.2018.05.007 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"46997_CR11","doi-asserted-by":"publisher","first-page":"108892","DOI":"10.1016\/j.biopha.2019.108892","volume":"115","author":"A Udristioiu","year":"2019","unstructured":"Udristioiu, A. & Nica-Badea, D. Autophagy dysfunctions associated with cancer cells and their therapeutic implications. Biomed. Pharmacother. 115, 108892. https:\/\/doi.org\/10.1016\/j.biopha.2019.108892 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"46997_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/cr.2013.161","volume":"24","author":"P Jiang","year":"2014","unstructured":"Jiang, P. & Mizushima, N. Autophagy and human diseases. Cell. Res. 24, 69\u201379. https:\/\/doi.org\/10.1038\/cr.2013.161 (2014).","journal-title":"Cell. Res."},{"key":"46997_CR13","doi-asserted-by":"publisher","first-page":"578418","DOI":"10.3389\/fonc.2020.578418","volume":"10","author":"R Chavez-Dominguez","year":"2020","unstructured":"Chavez-Dominguez, R., Perez-Medina, M., Lopez-Gonzalez, J. S., Galicia-Velasco, M. & Aguilar-Cazares, D. The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity. Front. Oncol. 10, 578418. https:\/\/doi.org\/10.3389\/fonc.2020.578418 (2020).","journal-title":"Front. Oncol."},{"key":"46997_CR14","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1158\/1078-0432.CCR-07-5023","volume":"15","author":"E White","year":"2009","unstructured":"White, E. & DiPaola, R. S. The Double-Edged Sword of Autophagy Modulation in Cancer. Clin. Cancer Res. 15, 5308\u20135316. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-5023 (2009).","journal-title":"Clin. Cancer Res."},{"key":"46997_CR15","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/45257","volume":"402","author":"XH Liang","year":"1999","unstructured":"Liang, X. H. et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402, 672\u2013676. https:\/\/doi.org\/10.1038\/45257 (1999).","journal-title":"Nature"},{"key":"46997_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrc3262","volume":"12","author":"E White","year":"2012","unstructured":"White, E. Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer. 12, 401\u2013410. https:\/\/doi.org\/10.1038\/nrc3262 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"46997_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12943-019-1030-2","volume":"18","author":"H-T Chen","year":"2019","unstructured":"Chen, H-T. et al. Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy. Mol. Cancer. 18, 101. https:\/\/doi.org\/10.1186\/s12943-019-1030-2 (2019).","journal-title":"Mol. Cancer"},{"key":"46997_CR18","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1158\/0008-5472.CAN-12-2432","volume":"73","author":"I Akalay","year":"2013","unstructured":"Akalay, I. et al. Epithelial-to-Mesenchymal Transition and Autophagy Induction in Breast Carcinoma Promote Escape from T-cell-Mediated Lysis. Cancer Res. 73, 2418\u20132427. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-2432 (2013).","journal-title":"Cancer Res."},{"key":"46997_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12964-021-00769-0","volume":"19","author":"Y Duan","year":"2021","unstructured":"Duan, Y. et al. Role of autophagy on cancer immune escape. Cell. Commun. Signal. 19, 91. https:\/\/doi.org\/10.1186\/s12964-021-00769-0 (2021).","journal-title":"Cell. Commun. Signal."},{"key":"46997_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1158\/0008-5472.CAN-13-2966","volume":"74","author":"DA Gewirtz","year":"2014","unstructured":"Gewirtz, D. A. The Four Faces of Autophagy: Implications for Cancer Therapy. Cancer Res. 74, 647\u2013651. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2966 (2014).","journal-title":"Cancer Res."},{"key":"46997_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI73939","volume":"125","author":"YC Kim","year":"2015","unstructured":"Kim, Y. C. & Guan, K-L. mTOR: a pharmacologic target for autophagy regulation. J. Clin. Invest. 125, 25\u201332. https:\/\/doi.org\/10.1172\/JCI73939 (2015).","journal-title":"J. Clin. Invest."},{"key":"46997_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12935-018-0557-4","volume":"18","author":"S Aveic","year":"2018","unstructured":"Aveic, S. et al. Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors. Cancer Cell. Int. 18, 63. https:\/\/doi.org\/10.1186\/s12935-018-0557-4 (2018).","journal-title":"Cancer Cell. Int."},{"key":"46997_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4161\/auto.27719","volume":"10","author":"DA Gewirtz","year":"2014","unstructured":"Gewirtz, D. A. When cytoprotective autophagy isn\u2019t\u2026 and even when it is. Autophagy 10, 391\u2013392. https:\/\/doi.org\/10.4161\/auto.27719 (2014).","journal-title":"Autophagy"},{"key":"46997_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/biology9010012","volume":"9","author":"DA Gewirtz","year":"2020","unstructured":"Gewirtz, D. A. The Switch between Protective and Nonprotective Autophagy; Implications for Autophagy Inhibition as a Therapeutic Strategy in Cancer. Biology 9, 12. https:\/\/doi.org\/10.3390\/biology9010012 (2020).","journal-title":"Biology"},{"key":"46997_CR25","doi-asserted-by":"publisher","first-page":"100750","DOI":"10.1016\/j.bbrep.2020.100750","volume":"22","author":"H Tanaka","year":"2020","unstructured":"Tanaka, H. et al. Comparison of autophagy inducibility in various tyrosine kinase inhibitors and their enhanced cytotoxicity via inhibition of autophagy in cancer cells in combined treatment with azithromycin. Biochem. Biophys. Rep. 22, 100750. https:\/\/doi.org\/10.1016\/j.bbrep.2020.100750 (2020).","journal-title":"Biochem. Biophys. Rep."},{"key":"46997_CR26","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.4161\/auto.7.10.16818","volume":"7","author":"Y-H Shi","year":"2011","unstructured":"Shi, Y-H. et al. Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. Autophagy 7, 1159\u20131172. https:\/\/doi.org\/10.4161\/auto.7.10.16818 (2011).","journal-title":"Autophagy"},{"key":"46997_CR27","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1158\/1078-0432.CCR-12-1542","volume":"19","author":"M Selvakumaran","year":"2013","unstructured":"Selvakumaran, M., Amaravadi, R. K., Vasilevskaya, I. A. & O\u2019Dwyer, P. J. Autophagy Inhibition Sensitizes Colon Cancer Cells to Antiangiogenic and Cytotoxic Therapy. Clin. Cancer Res. 19, 2995\u20133007. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1542 (2013).","journal-title":"Clin. Cancer Res."},{"key":"46997_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1254\/jphs.12158FP","volume":"121","author":"T Ikeda","year":"2013","unstructured":"Ikeda, T. et al. Inhibition of Autophagy Enhances Sunitinib-Induced Cytotoxicity in Rat Pheochromocytoma PC12 cells. J. Pharmacol. Sci. 121, 67\u201373. https:\/\/doi.org\/10.1254\/jphs.12158FP (2013).","journal-title":"J. Pharmacol. Sci."},{"key":"46997_CR29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(12)61900-X","volume":"381","author":"A Grothey","year":"2013","unstructured":"Grothey, A. et al. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet 381, 303\u2013312. https:\/\/doi.org\/10.1016\/S0140-6736(12)61900-X (2013).","journal-title":"Lancet"},{"key":"46997_CR30","doi-asserted-by":"publisher","first-page":"pkae017","DOI":"10.1093\/jncics\/pkae01","volume":"8","author":"PM Boland","year":"2024","unstructured":"Boland, P. M. et al. A phase I\/II study of nintedanib and capecitabine for refractory metastatic colorectal cancer. JNCI Cancer Spectr. 8, pkae017. https:\/\/doi.org\/10.1093\/jncics\/pkae01 (2024).","journal-title":"JNCI Cancer Spectr."},{"key":"46997_CR31","doi-asserted-by":"publisher","first-page":"6522","DOI":"10.1158\/1078-0432.CCR-11-1607","volume":"17","author":"V Poindessous","year":"2011","unstructured":"Poindessous, V. et al. EGFR- and VEGF(R)-Targeted Small Molecules Show Synergistic Activity in Colorectal Cancer Models Refractory to Combinations of Monoclonal Antibodies. Clin. Cancer Res. 17, 6522\u20136530. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1607 (2011).","journal-title":"Clin. Cancer Res."},{"key":"46997_CR32","doi-asserted-by":"publisher","first-page":"11316","DOI":"10.1038\/s41598-019-47659-7","volume":"9","author":"A Lauzier","year":"2019","unstructured":"Lauzier, A. et al. Colorectal cancer cells respond differentially to autophagy inhibition in vivo. Sci. Rep. 9, 11316. https:\/\/doi.org\/10.1038\/s41598-019-47659-7 (2019).","journal-title":"Sci. Rep."},{"key":"46997_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cell.2006.08.033","volume":"127","author":"E Jacinto","year":"2006","unstructured":"Jacinto, E. et al. SIN1\/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity. Cell 127, 125\u2013137. https:\/\/doi.org\/10.1016\/j.cell.2006.08.033 (2006).","journal-title":"Cell"},{"key":"46997_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.devcel.2006.10.007","volume":"11","author":"DA Guertin","year":"2006","unstructured":"Guertin, D. A. et al. Ablation in Mice of the mTORC Components raptor, rictor, or mLST8 Reveals that mTORC2 Is Required for Signaling to Akt-FOXO and PKC\u03b1, but Not S6K1. Dev. Cell. 11, 859\u2013871. https:\/\/doi.org\/10.1016\/j.devcel.2006.10.007 (2006).","journal-title":"Dev. Cell"},{"key":"46997_CR35","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1007\/s00018-017-2481-5","volume":"74","author":"VC Figueiredo","year":"2017","unstructured":"Figueiredo, V. C., Markworth, J. F. & Cameron-Smith, D. Considerations on mTOR regulation at serine 2448: implications for muscle metabolism studies. Cell. Mol. Life Sci. 74, 2537\u20132545. https:\/\/doi.org\/10.1007\/s00018-017-2481-5 (2017).","journal-title":"Cell. Mol. Life Sci."},{"key":"46997_CR36","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1158\/0008-5472.CAN-07-6307","volume":"68","author":"F Hilberg","year":"2008","unstructured":"Hilberg, F. et al. BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy. Cancer Res. 68, 4774\u20134782. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-6307 (2008).","journal-title":"Cancer Res."},{"key":"46997_CR37","doi-asserted-by":"publisher","unstructured":"M\u00e9sange, P. et al. Intrinsic bevacizumab resistance is associated with prolonged activation of autocrine VEGF signaling and hypoxia tolerance in colorectal cancer cells and can be overcome by Nintedanib, a small molecule angiokinase inhibitor. Oncotarget 5 https:\/\/doi.org\/10.18632\/oncotarget.1671 (2014).","DOI":"10.18632\/oncotarget.1671"},{"key":"46997_CR38","doi-asserted-by":"publisher","first-page":"594","DOI":"10.4161\/cc.11.3.19096","volume":"11","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y. & Zheng, X. F. S. mTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors. Cell. Cycle. 11, 594\u2013603. https:\/\/doi.org\/10.4161\/cc.11.3.19096 (2012).","journal-title":"Cell. Cycle"},{"key":"46997_CR39","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41401-018-0020-z","volume":"40","author":"M Gao","year":"2019","unstructured":"Gao, M. et al. Aberrant modulation of ribosomal protein S6 phosphorylation confers acquired resistance to MAPK pathway inhibitors in BRAF-mutant melanoma. Acta Pharmacol. Sin. 40, 268\u2013278. https:\/\/doi.org\/10.1038\/s41401-018-0020-z (2019).","journal-title":"Acta Pharmacol. Sin"},{"key":"46997_CR40","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1182\/blood-2013-03-488486","volume":"122","author":"S Bruneau","year":"2013","unstructured":"Bruneau, S., Nakayama, H., Woda, C. B., Flynn, E. A. & Briscoe, D. M. DEPTOR regulates vascular endothelial cell activation and proinflammatory and angiogenic responses. Blood 122, 1833\u20131842. https:\/\/doi.org\/10.1182\/blood-2013-03-488486 (2013).","journal-title":"Blood"},{"key":"46997_CR41","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1128\/MCB.00306-14","volume":"35","author":"S Wang","year":"2015","unstructured":"Wang, S. et al. Regulation of Endothelial Cell Proliferation and Vascular Assembly through Distinct mTORC2 Signaling Pathways. Mol. Cell. Biol. 35, 1299\u20131313. https:\/\/doi.org\/10.1128\/MCB.00306-14 (2015).","journal-title":"Mol. Cell. Biol."},{"key":"46997_CR42","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.yexcr.2014.08.001","volume":"327","author":"J-H Kim","year":"2014","unstructured":"Kim, J-H. et al. Raf\/MEK\/ERK can regulate cellular levels of LC3B and SQSTM1\/p62 at expression levels. Exp. Cell Res. 327, 340\u2013352. https:\/\/doi.org\/10.1016\/j.yexcr.2014.08.001 (2014).","journal-title":"Exp. Cell Res."},{"key":"46997_CR43","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1038\/ncomms3799","volume":"4","author":"N Martinez-Lopez","year":"2013","unstructured":"Martinez-Lopez, N., Athonvarangkul, D., Mishall, P., Sahu, S. & Singh, R. Autophagy proteins regulate ERK phosphorylation. Nat. Commun. 4, 2799. https:\/\/doi.org\/10.1038\/ncomms3799 (2013).","journal-title":"Nat. Commun."},{"key":"46997_CR44","doi-asserted-by":"publisher","first-page":"14056","DOI":"10.1074\/jbc.M700906200","volume":"282","author":"PP Roux","year":"2007","unstructured":"Roux, P. P. et al. RAS\/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation. J. Biol. Chem. 282, 14056\u201314064. https:\/\/doi.org\/10.1074\/jbc.M700906200 (2007).","journal-title":"J. Biol. Chem."},{"key":"46997_CR45","doi-asserted-by":"publisher","unstructured":"Corcoran, R. B. et al. TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in BRAF- Mutant Melanoma. Sci. Transl Med. 5. https:\/\/doi.org\/10.1126\/scitranslmed.3005753 (2013).","DOI":"10.1126\/scitranslmed.3005753"},{"key":"46997_CR46","doi-asserted-by":"publisher","first-page":"C1172","DOI":"10.1152\/ajpcell.00504.2010","volume":"300","author":"JN Winter","year":"2011","unstructured":"Winter, J. N., Jefferson, L. S. & Kimball, S. R. ERK and Akt signaling pathways function through parallel mechanisms to promote mTORC1 signaling. Am. J. Physiology-Cell Physiol. 300, C1172\u2013C1180. https:\/\/doi.org\/10.1152\/ajpcell.00504.2010 (2011).","journal-title":"Am. J. Physiology-Cell Physiol."},{"issue":"9","key":"46997_CR47","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1172\/JCI34739","volume":"118","author":"L Alimonti","year":"2008","unstructured":"Alimonti, L. et al. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J. Clin. Invest. 118 (9), 3065\u20133074. https:\/\/doi.org\/10.1172\/JCI34739 (2008).","journal-title":"J. Clin. Invest."},{"issue":"13","key":"46997_CR48","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-11-3747","volume":"72","author":"AB Turke","year":"2012","unstructured":"Turke, A. B. et al. MEK inhibition leads to PI3K\/AKT activation by relieving a negative feedback on ERBB receptors. Cancer Res. 72 (13), 3228\u20133237. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3747 (2012).","journal-title":"Cancer Res."},{"key":"46997_CR49","doi-asserted-by":"publisher","first-page":"1045521","DOI":"10.3389\/fonc.2022.1045521","volume":"12","author":"A Stulpinas","year":"2023","unstructured":"Stulpinas, A. et al. Crosstalk between protein kinases AKT and ERK1\/2 in human lung tumor-derived cell models. Front. Oncol. 12, 1045521. https:\/\/doi.org\/10.3389\/fonc.2022.1045521 (2023).","journal-title":"Front. Oncol."},{"key":"46997_CR50","doi-asserted-by":"publisher","first-page":"6109979","DOI":"10.1016\/j.isci.2024.109979","volume":"27","author":"M Tufail","year":"2024","unstructured":"Tufail, M. et al. Hallmarks of cancer resistance. iScience 27, 6109979. https:\/\/doi.org\/10.1016\/j.isci.2024.109979 (2024).","journal-title":"iScience"},{"key":"46997_CR51","unstructured":"Cancer Genome Atlas Network 2012, (2015)."},{"key":"46997_CR52","doi-asserted-by":"publisher","first-page":"1631116","DOI":"10.3389\/fcell.2025.1631116","volume":"13","author":"G Agostini","year":"2025","unstructured":"Agostini, G. et al. Autophagy inhibition improves sensitivity to the multi-kinase inhibitor regorafenib in preclinical mouse colon tumoroids. Front. Cell. Dev. Biol. 13, 1631116. https:\/\/doi.org\/10.3389\/fcell.2025.1631116 (2025).","journal-title":"Front. Cell. Dev. Biol."},{"key":"46997_CR53","doi-asserted-by":"publisher","unstructured":"Pienkowski, K. W. P. T., Tankiewicz-Kwedlo, A., Ciborowski, M., Kurek, K. & Pawlak, D. Differences in treatment outcome between translational platforms in developing therapies for gastrointestinal cancers,European. J. Pharmacol. Volume. 991 https:\/\/doi.org\/10.1016\/j.ejphar.2025.177309 (2025).","DOI":"10.1016\/j.ejphar.2025.177309"},{"issue":"2","key":"46997_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3892\/mi.2024.212","volume":"5","author":"G Isinelli","year":"2025","unstructured":"Isinelli, G., Failla, S., Plebani, R. & Prete A.Exploring oncology treatment strategies with tyrosine kinase inhibitors through advanced 3D models. Med. Int. 5 (2), 13. https:\/\/doi.org\/10.3892\/mi.2024.212 (2025).","journal-title":"Med. Int."},{"key":"46997_CR55","doi-asserted-by":"publisher","first-page":"e3013","DOI":"10.1038\/cddis.2017.398","volume":"8","author":"C Bingel","year":"2017","unstructured":"Bingel, C. et al. Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistance. Cell. Death Dis. 8, e3013. https:\/\/doi.org\/10.1038\/cddis.2017.398 (2017).","journal-title":"Cell. Death Dis."},{"key":"46997_CR56","doi-asserted-by":"publisher","unstructured":"Soares, D. G. et al. Replication and homologous recombination repair regulate DNA double-strand break formation by the antitumor alkylator ecteinascidin 743. Proceedings of the National Academy of Sciences. ;104:13062\u20137. (2007). https:\/\/doi.org\/10.1073\/pnas.0609877104","DOI":"10.1073\/pnas.0609877104"},{"key":"46997_CR57","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1242\/jcs.023259","volume":"121","author":"AE Escargueil","year":"2008","unstructured":"Escargueil, A. E. et al. Influence of irofulven, a transcription-coupled repair-specific antitumor agent, on RNA polymerase activity, stability and dynamics in living mammalian cells. J. Cell Sci. 121, 1275\u20131283. https:\/\/doi.org\/10.1242\/jcs.023259 (2008).","journal-title":"J. Cell Sci."},{"key":"46997_CR58","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/s41598-017-01866-2","volume":"7","author":"N Ferrand","year":"2017","unstructured":"Ferrand, N. et al. WISP1\/CCN4 inhibits adipocyte differentiation through repression of PPAR\u03b3 activity. Sci. Rep. 7, 1749. https:\/\/doi.org\/10.1038\/s41598-017-01866-2 (2017).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46997-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46997-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46997-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T23:41:12Z","timestamp":1779752472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46997-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46997"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46997-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16233"}}